Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study Source: ERJ Open Res, 8 (1) 00628-2021; 10.1183/23120541.00628-2021 Year: 2022
Changes in physical activity and all-cause mortality in COPD Source: Eur Respir J 2014; 44: 1199-1209 Year: 2014
Age cohort mortality differences for respiratory and cardiovascular causes of death Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001
All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age Source: Eur Respir J 2005; 25: 514-520 Year: 2005
Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021
Asthma and all-cause mortality in children and young adults - a Swedish population based study Source: International Congress 2019 – Early origins of respiratory diseases and later life consequences Year: 2019
Incident asthma in adults - young women have the highest risk Source: Eur Respir J 2004; 24: Suppl. 48, 500s Year: 2004
All-cause mortality in adults with incident asthma – a 20-year follow-up study of a large population-based cohort of middle-aged Danish adults Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019
OSA and cardiovascular risk in women Source: 5th Sleep and Breathing Conference Year: 2019
Respiratory symptoms and two years‘ mortality in a French elderly cohort Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005
Association of symptom subtypes and obstructive sleep apnoea-specific hypoxic burden with cardiovascular morbidity and all-cause mortality Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021
Covid-19 and gender: lower rate, but same mortality of severe disease in women Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021
Increased relative mortality in women with severe oxygen-dependent COPD Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Source: Eur Respir J 2005; 25: 587-588 Year: 2005
Impact of nocturnal oximetry on mortality and cardiovascular consequences in the general population after 20 years of follow up Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders Year: 2020
COPD the unseen factor causing increased morbidity and mortality among IHD patients Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009
Serotonergic antidepressant use and morbidity and mortality among older adults with COPD Source: Eur Respir J, 52 (1) 1800475; 10.1183/13993003.00475-2018 Year: 2018
Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021
10-year follow-up of hospitalised COPD-patients: Comorbidities, mortality and cause of death Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up. Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders Year: 2020